Nobel Biocare extends syndicated line
Switzerland’s Nobel Biocare has signed an extension to its Eu330m syndicated loan, pushing the maturity out from 2012 to 2015.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
